14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

$3.86 (-3.02%)

Volume: 2.295M

Closed: Sep 26, 2022

Hollow Logo Score: -1.789

Heron Therapeutics Stock Forecast

$3.86 (-3.02%)

Volume: 2.295M

Closed: Sep 26, 2022

Score Hollow Logo -1.789
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSI min/max Values: [ 25 - 75 ] RSI14 is 44 and the stock is currently not being overbought or oversold
Last Reaction
Be the first to comment on HRTX

Heron Therapeutics stock price down 3.02% on Monday
(Updated on Sep 26, 2022)


Sell candidate since 2022-09-21 Loss -10.85% PDF

The Heron Therapeutics stock price fell by -3.02% on the last day (Monday, 26th Sep 2022) from $3.98 to $3.86. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 8.70% from a day low at $3.85 to a day high of $4.19. The price has fallen in 8 of the last 10 days and is down by -19.92% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -958 thousand shares and in total, 2 million shares were bought and sold for approximately $8.86 million.

Given the current short-term trend, the stock is expected to rise 51.6% during the next 3 months and, with a 90% probability hold a price between $5.85 and $9.59 at the end of this 3-month period.

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Heron Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.35 and $4.56. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, August 16, 2022, and so far it has fallen -28.12%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $3.57 and $3.22. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Heron Therapeutics finds support just below today's level at $3.57. If this is broken, then the next support from accumulated volume will be at $3.22 and $2.94.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.34 between high and low, or 8.70%. For the last week, the stock has had daily average volatility of 8.88%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations For The Upcoming Trading Day Of Tuesday 27th

For the upcoming trading day on Tuesday, 27th we expect Heron Therapeutics to open at $3.97, and during the day (based on 14 day Average True Range), to move between $3.46 and $4.26, which gives a possible trading interval of +/-$0.40 (+/-10.40%) up or down from last closing price. If Heron Therapeutics takes out the full calculated possible swing range there will be an estimated 20.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.11 (6.48%) than the support at $3.57 (7.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Heron Therapeutics stock A Buy?

The Heron Therapeutics stock holds several negative signals and despite the positive trend, we believe Heron Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.789

Sell Candidate Unchanged

Predicted Opening Price for Heron Therapeutics of Tuesday, September 27, 2022

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price September 27, 2022 Current price
$3.97 $3.86 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 4.30 11.40 %
4.17 8.08 %
4.09 6.04 %
Current price: 3.86
Support 3.84 -0.60 %
3.76 -2.64 %
3.63 -5.96 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 4.70 21.76 %
4.67 20.98 %
4.11 6.48 %
Current price 3.86
Support 3.57 -7.51%
3.22 -16.58%
2.94 -23.83%

Click to get the best stock tips daily for free!

Hot Stocks To Watch:

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 27 084 stocks, only a few dozen will trigger such a signal!

About Heron Therapeutics

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut... HRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT